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ABSTRACT 
DNA photosensitizers are compounds that are capable of binding in to DNA strands through 
groove binding, intercalation, or electrostatic interactions.  Excitation of these agents by light 
generates reactive oxygen species which causes extensive photo-oxidative damage to genomic 
DNA.  Physiological concentrations of NaCl and KCl are ~ 150 mM and 260 mM within the cell 
nucleus where DNA is contained.  Unfortunately, the ability of most photosensitizers to bind to 
double-helical DNA is reduced and photocleavage yields are diminished as concentrations of salt 
increase. The aim of this project is to observe the photocleavage of pUC19 plasmid DNA 
induced by N1,N1-bis(9-anthrymethyl)triethylenetetraamine tetrahydrochloride (AL-VIII 23) 1 or 
N,N-dimethyl-N’-(9-methylanthracenyl)ethylenediamine (NMEA) 2 in presence of salt.  
Spectroscopic titrations and DNA melting assays were used to study binding modes and 
affinities of both dyes to the helix upon the addition of salt. 
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1. Introduction 
1.1 Brief Overview of Photodynamic Therapy 
Photodynamic therapy (PDT) is a clinical procedure that involves the administration of a 
photosensitizer to a target cell to induce necrosis or apoptosis [1].  This procedure is used mostly 
for treatment of superficial lesions of malignant and non-malignant diseases.  The process 
involves the administration of small quantities of a photosensitizing drug and irradiation of the 
target tissue with visible light (~500 - 800 nm). A photosensitizer is a compound that produces 
reactive oxygen species (ROS) when excited by a photon of light of a specific wavelength. The 
generation of these ROS leads to a series of photochemical reactions that consequently lead to 
DNA damage thereby inhibiting transcription and cell replication.  Factors that contribute to cell 
damage include the location and concentration of photosensitizer administered [2]. Since the 
discovery of photodynamic therapy as a treatment for cancerous tumors, the need to discover 
new and efficient photosensitizers has grown tremendously.    
Phototherapy has been applied by humans to treat various diseases for over 3000 years. 
Ancient Greek civilizations (~ 2nd century B.C.) believed heliotherapy was the healing ability of 
the sun to restore human health [3].  The term ‘photodynamic action’ originated from Professor 
Herman von Tappeiner, director of Pharmacology Institute of Ludwig-Maximilians University in 
Munich in 1904.  He attempted the use of several dyes for PDT treatment of tumors and skin 
diseases such as lupus chondylomata [3].  In 1903, a Nobel Prize in Medicine was awarded to 
Niels Finsen for his work in phototherapy, using carbon arc for treatment of lupus vulgaris [4].  
In 1943, Auler and Banzer reported the use of a porphyrin derivative haematoporphyrin (Figure 
1.1) as a photosensitizer to treat tumor cells.  They reported that the compound showed a high 
affinity for primary and metastatic tumor cells than healthy cells [5, 6].  As research progressed 
  
 
in this field, Lipson et al. designed
and phototoxicity for cancer cells
in photo treatment of cancerous tumor 
Doughery and his colleagues at Roswell Park Memorial Cancer Institute
(Figure 1.2) [8].  It was the first FDA approved drug used for PDT.  Upon irradiation with red
light, Photofrin I was capable of inhibi
limited to treatment of near surface tumors
Foscan, and Laserphyrin were also
Figure 1.1:  Structure of hematoporphyrin
 
Figure 1.2:  A component of Photofrin 1, the first FDA approved drug used for photodynamic 
therapy.  Image was reproduced from reference
 a haematoporphrin derivative (HpD) that had a higher affinity
 [7]. This derivative became the first synthetic compound used 
[6]. Through further purification of HpD, Thomas 
 developed Photofrin I 
ting tumor growth in humans but its applications were 
 [3, 6]. Subsequently, drugs such as Levulan, Metvis, 
 approved for clinical use [3]. 
  
. 
 [9]. 
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1.2 Photo-excitation of Photosentizers 
Photosensitizing compounds usually possess conjugated π ring systems.  Most 
photosensitizers have fluorescence emission spectra that overlap with their absorption spectra.  
Some of them show strong absorbance in the red region of the spectrum [2].  Most scientists 
agree that the qualities of an ideal photosensitizer would include a high extinction coefficient, 
high quantum yield of singlet oxygen, low dark toxicity, long absorbing wavelength, and rapid 
removal from the body [10].  The compounds are administered either topically or by injecting the 
photosensitizer into the blood stream and exposing the target tissue to light once the 
photosensitizer is localized in the target cell [11].  Most photosensitizers tend to bind to tumor 
cells with greater affinity than normal cells and it is necessary to wait for the compound to be 
flushed out of the normal cells before activation and production of cytotoxic species [10].  
Photosensitizers are capable of causing DNA damage through Type I and Type II 
oxidative pathways (Figure 1.3).  When a photosensitizer is exposed to light, a singlet state (1P) 
is produced by absorption of electromagnetic radiation.  The singlet state can then undergo 
intersystem crossing to produce a triplet state [12].  Type 1 reactions involve a direct transfer of 
an electron to the molecular oxygen or from DNA nucleobases, preferentially guanine to the 
excited state photosensitizer, leading to the generation of superoxide ion radicals (O2•-) and DNA 
base oxidation.  The oxidation of guanine typically leads to the formation of 7,8-dihydro-8-
oxoguanine (8-oxoG).  The formation of superoxide anions leads to the production of hydroxyl 
radicals (•OH), generated via the Fenton reaction [13].  The presence of hydroxyl radicals leads 
to the abstraction of hydrogen atoms from the deoxyribose sugar, forming alkali-labile lesions 
and direct strand cleavage.  Hydroxyl radicals can also cause direct oxidation of DNA bases, 
preferentially C-8 of guanine, leading again to the formation of 8-oxoG.  In Type II reactions, 
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energy is transferred from the excited triplet state of the photosensitizer to the triplet ground state 
of molecular oxygen, leading to the formation singlet oxygen which preferentially oxidizes 
guanine [13-16]. Both pathways are toxic to the cell and can induce necrosis or apoptosis of 
living tissue. 
 
 
Figure 1.3: Scheme of DNA damage by photosensitizer reproduced from reference [12]. 
 
1.3 Non-covalent Interactions with DNA 
Photosensitizers interact with DNA through three possible binding modes: electrostatic 
external interactions, groove binding, and intercalation (Figure 1.4) [1].  These various modes of 
binding have different effects on DNA conformation and initiation of photoreactions.  This thesis 
will focus on groove binding and intercalation modes of interaction. 
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Figure 1.4: Non-covalent DNA binding modes reproduced from reference [17]. 
1.3.1 Groove Binding Compounds 
DNA groove binders interact with either the major or minor grooves of the helix.  Large 
molecules like proteins tend to bind primarily to the major groove while smaller molecules prefer 
the minor groove of DNA [18].  The smaller molecules are usually composed of small aromatic 
rings such as pyrroles, furans, and benzenes linked by amide groups.  They may also possess 
crescent shapes with appropriate twist to fit into the curve of the minor groove.  When the 
compound is fitted properly into the minor groove, water molecules are displaced from the 
groove and the compound forms van der Waals contacts with the groove walls [18].  Groove 
binder molecules show some sequence specificity with a majority showing hydrogen bonding 
preference to A-T rich sequences [19].  The amino group hydrogen of the amide bond between 
the aromatic rings are capable of hydrogen bonding to the C-2 carbonyl oxygen of thymine or N-
3 nitrogen of adenine.  A similar interaction with guanine and cytosine bases is unlikely due to 
the added steric bulk of the G-NH2 [18]. 
 
6 
 
 
 
1.3.2 Intercalating Compounds 
Intercalators are molecules that bind to DNA by insertion between the base pairs.  
Intercalators can be grouped into mono, bis, and threading intercalators.  Most intercalators are 
planar molecules containing fused aromatic rings with a charged side chain attached to the ring.  
The planarity of the ring system favors stacking with the DNA base pairs [20].  As the compound 
binds between the bases, the helix conformation is altered [21]. There is a localized unwinding of 
helix and an increase in the helical rise as the compound binds.  The unwinding and lengthening 
of the DNA strands causes and increase in the viscosity of the solution [22]. 
Most intercalators abide by the nearest neighbor exclusion principle when they bind to 
DNA [23].  This principle is based on the theory that most intercalators bind between every other 
DNA base pair to reach saturation.  The flexibility of the linker also plays a major role in the 
ability of the compound to intercalate.  Polyamine linkers such as spermine bind across the major 
groove of B-form DNA and interact with the negatively charged phosphate groups.  Polyamines 
are usually protonated under physiological conditions. Based on its net charge, a linker might be 
capable of forming salt bridges with the phosphate back bone [1]. 
Scientists have synthesized bis-intercalators with varying lengths of linkers to test the 
effects on the linker length on intercalation position [23]. A bis-intercalator is a compound that 
contains two polycylic aromatic hydrocarbons connected by a linker (Figure 1.5).  They are 
capable of binding simultaneously to two sets of DNA base pairs. By shortening or lengthening 
its linker, the distance of the intercalation can be somewhat controlled [23].  Some examples of 
bis-intercalators include ditercalinium, echinomycin, and triostin A [18, 24].   
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Figure 1.5: Image of possible conformations of a bis-intercalator reproduced from reference [25]. 
1.4 Anthracene Based DNA Interactions 
Anthracenes are made up of three planar fused aromatic rings.  They fall under the 
category of fluorescent dye photosensitizers.  They are capable of light dependent chemical 
reactions that result in damage of biological systems.  Anthracenes are good photosensitizers 
because of their low polarizability, strong fluorescence, good absorption in the near UV region, 
and a long-lived excited triplet state [26].  They are capable of producing ROS through either 
type I and type II reaction pathways.  Anthracenes produce singlet oxygen by energy transfer 
from their singlet and triplet excited states when irradiated with light [20, 27].  Mechanisms of 
cleavage include hydrogen abstraction from the sugar ring by photochemically generated 
radicals, direct electron transfer from the base (usually guanine) to the excited photosensitizer, 
singlet oxygen production by transfer of energy from the excited photosensitizer, and formation 
of base adducts with the photosensitizer.  The production of radicals and reactive oxygen species 
produces extensive phototoxic damage to DNA by forming alkaline labile lesions and direct 
strand breaks at guanine bases [14]. 
The cleavage of DNA is important because it could lead to apoptosis or necrosis of the 
cells.  When anthracene based photosensitizers are introduced to tissue they are known to 
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possess anti-tumor and anti-viral activity.  When linked to a primary alkyl amine, they can 
undergo photochemical reactions with nucleotides that induce DNA strand scission [20].  The 
two major bind modes of anthracene chromophores are intercalation and groove binding.  Large 
substituents on the anthracene ring are known to inhibit intercalation due to steric clash with the 
amino group of guanine in the minor groove [26].  These compounds bind to the DNA through 
either the major or minor grooves.  Based on the structure and net charge of the compound, it 
could also form electrostatic interactions with the phosphate backbone or be a threading 
intercalator.  
One of the many challenges of designing new anthracene-based photosensitizers is 
determining its binding mode and affinity to DNA.  Several anthracenes are known to intercalate 
between DNA base pairs [20, 26].  Most intercalators show preferential binding to alternating 
purine-pyrimidine sequences [20].  Spectroscopic characteristics of intercalation include strong 
hyprochromism, red shifts in vibronic bands, lengthening of excited state lifetime, induced 
circular dichorism, and increased stability of the DNA helix.  Observed large hypochromism 
suggests that the anthryl chromophore is in close proximity to the bases [20].  There are several 
methods of evaluating anthryl binding mode including UV-visible titrations, DNA melting 
studies,1H and 31P NMR, and isothermal calorimetry, as well as linear and circular dichroism 
studies [26, 28].  Based on spectroscopic data, the binding affinity of the anthryl chromophore 
can be determined.   
Several anthracyclines and anthracenediones have been approved by the FDA for 
treatment of diseases such as lung cancer, breast cancer, lymphoid and myeloid leukemia.  
Examples of such compounds include daunorubicin, dactinomycin, mitoxantrone, and 
doxorubicin [29]. These anthryl chromophores are photosensitive compounds, yielding high 
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cytotoxicity and inducing double strand DNA breaks when activated by light.  They are also 
known to bind to DNA through intercalation [30]. 
1.5 Goal 
This research focuses on the study of anthracene chromophores with respect to their 
ability to induce DNA damage for future use in PDT.  These compounds are expected to bind to 
DNA via intercalation or groove binding and induce photocleavage when irradiated by light.  
Previous research done by the Grant and Lorente groups showed that anthracene chromophores 
are capable of binding to DNA via groove binding or intercalation and inducing cleavage of the 
helix when activated by UV light.  Spectroscopic studies showed that there is a change in 
anthracene binding mode when 150 mM of NaCl and 260 mM KCl are added to the reaction 
[31].  Under conditions of increased ionic strength, phosphate-phosphate repulsion is decreased.  
This results in the decreased groove binding and intercalation and also contraction of the helix 
[32].  
The compounds shown below were capable of inducing cleavage to double stranded 
DNA when activated by 350 nm light.  Photocleavage reactions were performed using pUC19 
plasmid DNA isolated from the bacterium E. coli.  This plasmid DNA is a double stranded, 
circular supercoiled accessory chromosome containing 2686 base pairs.  It is commonly used in 
DNA related experiments because it has a high copy number, is inexpensive, relatively small in 
size, and readily available.  The photocleavage experiments were conducted with the aim of 
mimicking physiological conditions within the cell nucleus using 10 mM phosphate buffer (pH 
7.0), 150 mM NaCl and 260 mM KCl [33 – 35].  Studies have shown that the presence of salt 
decreases the binding affinity of photosensitizers to DNA helix thereby reducing photocleavage 
yields [21, 32].  Photocleavage studies were done to evaluate the extent of DNA damage when 
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these compounds were irradiated by 350 nm light. UV-visible and DNA melting studies were 
also done to evaluate binding modes of the ligand to the DNA.   
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N1,N1-bis(9-anthrymethyl)triethylenetetraamine 4 HCl (AL-VIII 23) (1) 
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N,N-dimethyl-N’-(9-methylanthracenyl)ethylenediamine (NMEA) (2) 
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2 Experimental 
2.1 General Methods 
 
Sodium chloride was purchased from EMD Chemical Inc (Gibbstown, NJ).  Agarose, 9-
anthraldehyde, potassium chloride, N,N-dimethylethylendiamine, bromophenol blue, and Ficoll 
type 400 were purchased from Sigma Aldrich (St. Louis, MO).  Tris base and monobasic sodium 
phosphate were from Fisher Scientific (Fairlawn, NJ).  Xylene cyanol FF was purchased from 
Eastman Kodak (Rochester, NY).  UltraPure TM calf thymus DNA solution ~ 2000 bp was from 
Invitrogen (Carlsbad, CA). DNA concentration was quantitated using Beer’s Law with an 
extinction coefficient of 12,824 M-1 (bp) cm-1 at 260 nm.  The pUC19 plasmid was cloned by 
Carla Terry (Georgia State University) according the procedures described in the literature [36].   
Samples were weighed on an analytical balance (Mettler Toledo B154, Switzerland).  
Photocleavage of pUC19 DNA was carried out using twelve 350 nm light bulbs (12 inches) in a 
Rayonet Photochemical Reactor (Model PRP-100, Southern New England Ultra Violet 
Company, Branford, CT).  Gel electrophoresis was carried out using an Owl horizontal 
electrophoresis system (ThermoScientific, Rochester, NY) attached to a VWR 105 Voltmeter 
(VWR Scientific, E-C Apparatus).   Gel images were captured using a Canon Powershot A640 
digital camera.  UV-visible experiments were carried out on a Shimadzu UV-1601 
spectrophotometer (Shimadzu Scientific Instruments Inc, Japan).  Thermal melting studies were 
conducted on a Cary Win Spectrophotometer (Varian Inc.).  Mass spectrometry analysis was 
conducted on a Water Q-TOFmicro, ABI API 3200 triple quadrupole ESI instrument and 1H 
NMR analysis was carried out on a Bruker Avance 400 NMR spectrometer.  
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2.2 Synthesis of N,N-dimethyl-N’-(9-methylanthracenyl)ethylenediamine 
 
Compound 2 was synthesis according to procedures described by Bag and Bharadwaj shown 
in Scheme 1 [37].  A solution of 9-anthraldehyde (1.2405g; 6.00 mmol) and ethanol (70 mL) was 
added to N,N-dimethylethylenediamine (0.70 mL; 6.00 mmol) and allowed to stir at room 
temperature for 36 h.  Excess NaBH4 (0.2765g) was added to the solution which was heated to 
reflux for 4 h. The reaction was monitored using aluminum thin layer chromatography (TLC) 
sheets (silica gel 60, EMD, Germany).  The solvent was removed under reduced pressure. The 
resulting yellow solid was stirred in 100 mL of water for 30 min and extracted with 40 mL 
dichloromethane.  The organic layer was dried over anhydrous MgSO4.  The remaining solvent 
was evaporated to dryness and a brown semi-solid product 2 was obtained (83% yield).  1H 
NMR (400 MHz, CDCl3, 25oC) 2.17 (s, 6H), 2.49 (s, 2H), 4.73 (s, 2H), 5.23 (s, 1H), 7.44 (t, 2H), 
7.52 (t, 2H), 7.52 (t, 2H), 7.88 (d, 2H), 8.42 (m, 3H).  ESI-MS (m/z) Anal. Calcd for C19H23N2 :  
[M+H]+ 279.1861, found: 279.1856. 
CHO
NH2
N
N N N N
+
 
Scheme 1: Synthesis of N,N-dimethyl-N’-(9-methylanthracenyl)ethylenediamine 
 
 
NaBH4 
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2.3 Preparation of Stock Solutions 
2.3.1 Preparation of ALVIII-23 
 
N1,N1-Bis(9-anthrymethyl)triethylenetramine tetrahydrochloride (1) was synthesized by 
Prof. Antonio Lorente at Universidad de Alcalá, Spain. Photocleavage samples were prepared by 
dissolving 0.0034 g of ALVIII-23 (F.W.= 672.55 g/mol) in 1.00 ml DMSO to make a 5 mM 
solution.  Samples were then diluted into ten 100 µM aliquots and stored in a freezer at -20 oC.  
2.3.2 Preparation of NMEA 
 
Compound 2 was prepared by dissolving 0.00143 g of 9-NMEA (F.W.= 285.82 g/mol) in 
1 ml DMSO to make a 5 mM solution.  Samples were then diluted into ten 100 µM aliquots and 
stored in a freezer at -20 oC.  
2.3.3 Preparation of NaCl and KCl 
 
Stock solutions of 1.0 M NaCl was prepared by dissolving 5.84 g NaCl (100 mmol) in 
100 mL autoclaved deionized water (ddH2O).  Potassium chloride stock solution was preparing 
similarly by dissolving 7.46 g KCl (100 mmol) in 100 mL ddH2O. 
2.3.4 Preparation of Sodium Phosphate Buffer 
 
Buffer made by preparing 1.0 M solutions of mono and dibasic sodium phosphate.  To 
prepare the monobasic salt, 35.49 g NaH2PO4 was dissolved in 250 mL ddH2O. The same 
amount of dibasic salt was also dissolved in 250 mL ddH2O.  Both monobasic and dibasic 
sodium phosphate solutions were diluted in ddH2O to a total volume of 1000 mL by combining 
57.7 mL of NaH2PO4 and 42.3 mL of Na2HPO4.  The pH was adjusted to 7.0 using 50% NaOH 
(19 M, Fisher Scientific).  
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2.3.5 Preperation of Tris Acetate EDTA Buffer 
 
A 50X buffer solution was prepared by diluting 242 g Tris base, 57.1 mL glacial acetic 
acid, 100 mL of 0.5 M EDTA (pH 8.0) to a total volume of 1000 mL. The buffer was then 
diluted to a 1X concentration using the equation below: 
M1V1 = M2V2 
 
 
2.4 Preparation of Photocleavage Samples 
2.4.1 Concentration Titrations with NaCl 
Photocleavage samples were prepared following the volumes listed in Tables 2.1 and 2.2 
for a total of 40 µL each.  The solutions were added to Eppendorf tubes in the order listed below. 
ddH2O 
100 mM Sodium phosphate buffer (pH 7) 
300 ng/µL pUC19 
100 µM or 10 µM Dye 
1 M NaCl 
 
 Samples were prepared with increasing concentrations of dye (0-10 µM) in the presence 
and absence of 150 or 260 mM NaCl and allowed to equilibrate in the dark for 60 min. For the 
1.0 and 0.5 µM dye concentrations the 100 µM stock solution was diluted to 10 µM in ddH2O.  
They were then aerobically irradiated for 60 min in a Rayonet Photochemical reactor fitted with 
twelve 350 nm lamps.  Negative controls remained in the dark while the photocleavage reaction 
proceeded. 
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Table 2.1: Photocleavage with addition 150 mM NaCl 
Units in µL (Total Volume 40 µL) 
[Stock] [Working] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Dye Concentration (µM) 10 5 2.5 1 0.5 0 10 10 5 2.5 1 0.5 0 10 
pUC19       
(300 ng/µL) 
pUC19            
(15 ng/µL) 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
Dye      
(100 µM) 
Dye 
(10 µM – 0 µM) 4 2 1 0.4 0.2 0 4 4 2 1 0.4 0.2 0 4 
Phos Buffer  
(100 mM) 
Phos Buffer  
(10 mM) 4 4 4 4 4 4 4 4 4 4 4 4 4 4 
NaCl         
 (1.0 M) 
NaCl            
(150 mM) 6 6 6 6 6 6 6 ~ ~ ~ ~ ~ ~ ~ 
  ddH2O 24 26 27 27.6 27.8 28 24 30 32 33 33.6 33.8 34 30 
  Light (60 min) (+) (+) (+) (+) (+) (+) (--) (+) (+) (+) (+) (+) (+) (--) 
 
 
Table 2.2: Photocleavage of addition of 260 mM NaCl 
Units in µL (Total Volume 40 µL) 
[Stock] [Working] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Dye Concentration (µM) 10 5 2.5 1 0.5 0 10 10 5 2.5 1 0.5 0 10 
pUC19       
(300 ng/µL) 
pUC19            
(15 ng/µL) 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
Dye 
(100 µM) 
Dye 
 (10 µM – 0 µM) 4 2 1 0.4 0.2 0 4 4 2 1 0.4 0.2 0 4 
Phos Buffer  
(100 mM) 
Phos Buffer  
(10 mM) 4 4 4 4 4 4 4 4 4 4 4 4 4 4 
NaCl        
  (1.0 M) 
NaCl           
 (260 mM) 10.4 10.4 10.4 10.4 10.4 10.4 10.4 ~ ~ ~ ~ ~ ~ ~ 
  ddH20 19.6 21.6 22.6 23.2 23.4 23.6 19.6 30 32 33 33.6 33.8 34 30 
  
Light  
(60 min) (+) (+) (+) (+) (+) (+) (--) (+) (+) (+) (+) (+) (+) (--) 
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2.4.2 Concentration Titration with KCl 
The samples were prepared by combining the following stock solutions into an Eppendorf 
tube and equilibrating in the dark for 60 min. 
ddH2O 
100 mM Sodium phosphate buffer (pH 7) 
300 ng/µL pUC19 
100 µM or 10 µM Dye 
1 M KCl 
 
The mixture was then placed in a Rayonet Photoreactor and aerobically (air) irradiated for 60 
min at 350 nm.  For the 1.0 and 0.5 µM dye concentrations the 100 µM stock solution was 
diluted to 10 µM in ddH2O.  Samples 7 and 14 from Table 2.3. remained in the dark while the 
others were being irradiated.  After 1 h elapsed, the samples were removed from the photoreactor 
and 3 µL of loading buffer (0.25% xylene cyanol FF, 0.25% bromophenol blue, 15% Ficoll Type 
400) was added to each tube for gel electrophoresis. 
 
Table 2.3:  Photocleavage with addition 260 mM KCl 
Units in µL (Total Volume 40 µL) 
[Stock] [Working] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Dye Concentration (µM) 10 5 2.5 1 0.5 0 10 10 5 2.5 1 0.5 0 10 
pUC19       
(300 ng/µL) 
pUC19            
(15 ng/µL) 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
Dye 
(100 µM) 
Dye 
 (10 µM – 0 µM) 4 2 1 0.4 0.2 0 4 4 2 1 0.4 0.2 0 4 
Phos Buffer  
(100 mM) 
Phos Buffer  
(10 mM) 4 4 4 4 4 4 4 4 4 4 4 4 4 4 
KCl        
  (1.0 M) 
KCl           
 (260 mM) 10.4 10.4 10.4 10.4 10.4 10.4 10.4 ~ ~ ~ ~ ~ ~ ~ 
  ddH20 19.6 21.6 22.6 23.2 23.4 23.6 19.6 30 32 33 33.6 33.8 34 30 
  
Light  
(60 min) (+) (+) (+) (+) (+) (+) (--) (+) (+) (+) (+) (+) (+) (--) 
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2.4.3 Concentration Titration with NaCl and KCl 
Photocleavage samples were prepared following the volumes listed in Table 1 and 2 at a 
total of 40 µL each.  The solutions were added to Eppendorf tubes in the order listed below. 
ddH2O 
100 mM Sodium phosphate buffer (pH 7) 
300 ng/µL pUC19 
100 µM or 10 µM Dye 
1 M NaCl 
 
 Individual samples containing increasing concentrations of dye (0-10 µM) in the presence 
or absence of 150 or 260 mM NaCl were allowed to equilibrate in the dark at room temperature 
for 60 min.  For the 1.0 and 0.5 µM dye concentrations the 100 µM stock solution was diluted to 
10 µM in ddH2O.  They were then aerobically irradiated for 60 min in a Rayonet Photochemical 
reactor.  Negative controls remained in the dark while the photocleavage reaction proceeded. 
Once the reaction time had elapsed, the samples were removed from the photoreactor and 3 µL 
of loading buffer was added to each tube and mixed homogenously.  
 
Table 2.4: Photocleavage with addition 150 mM NaCl and 260 mM KCl 
Units in mL (Total Volume 40 µL) 
[Stock] [Working] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
         Dye Concentration (µM) 10 5 2.5 1 0.5 0 10 10 5 2.5 1 0.5 0 10 
pUC19       
(300 ng/µL) 
pUC19           
(15 ng/µL) 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
AL- VIII     
(100 µM) 
AL-VIII 
(10 µM – 0 µM) 4 2 1 0.4 0.2 0 4 4 2 1 0.4 0.2 0 4 
Phos Buffer 
(100 mM) 
Phos Buffer 
 (10 mM) 4 4 4 4 4 4 4 4 4 4 4 4 4 4 
NaCl  
(1 M) 
NaCl  
(150 mM) 6 6 6 6 6 6 6 ~ ~ ~ ~ ~ ~ ~ 
KCl         
 (1.0 M) 
KCl          
  (260 mM) 10.4 10.4 10.4 10.4 10.4 10.4 10.4 ~ ~ ~ ~ ~ ~ ~ 
  ddH20 13.6 15.6 16.6 17.2 17.4 17.6 13.6 30 32 33 33.6 33.8 34 30 
  
Light  
(60 min) (+) (+) (+) (+) (+) (+) (--) (+) (+) (+) (+) (+) (+) (--) 
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2.4.4 Time Course Titration with NaCl and KCl 
Samples were prepared according to the order listed in Table 2.5 by adding the following 
solutions to an Eppendorf tube. 
ddH2O 
100 mM Sodium phosphate buffer (pH 7) 
300 ng/µL pUC19 
100 µM Dye 
1 M NaCl 
1 M KCl 
 
The samples were allowed to equilibrate in the dark for 1 h and aerobically (air) irradiated 
for 0-60 min in a Rayonet Photochemical reactor.  After the tubes were removed from the photo 
reactor, 3 µL of loading buffer was added to each solution and mixed homogenously. 
 
Table 2.5:  Time course titration 
Units in µL (Total Volume 40 µL) 
[Stock] [Working] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
AL- VIII Concentration (µM) 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 
pUC19 
(300 ng/µL) 
pUC19          
    (15 ng/µL) 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
AL- VIII     
 (100 µM) 
AL-VIII         
(2.5 µM) ~ ~ 1 1 1 1 1 ~ ~ 1 1 1 1 1 
Phos Buffer  
(100 mM) 
Phos Buffer 
(10 mM) 4 4 4 4 4 4 4 4 4 4 4 4 4 4 
NaCl 
(1 M) 
NaCl            
(150 mM) 6 6 6 6 6 6 6 ~ ~ ~ ~ ~ ~ ~ 
KCl KCl 
10.4 10.4 10.4 10.4 10.4 10.4 10.4 ~ ~ ~ ~ ~ ~ ~ (1 M) (260 mM) 
ddH20 17.6 17.6 16.6 16.6 16.6 16.6 16.6 34 34 33 33 33 33 33 
Light (min ) 0 60 0 8 10 20 60 0 60 0 8 10 20 60 
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2.5 Preparation of Agarose Gel Electrophoresis 
 
To prepare a 1.5% gel, 3.0 g agarose was dissolved in 200 mL 1X TAE buffer.  The 
mixture was heated to molten in a microwave and 20 µL of ethidium bromide (0.5 µg/mL in 
H2O) was added.  The liquid gel was poured into a gel box and allowed to set. Once the gel 
solidified, the box was filled with 1X TAE running buffer and 20 µL of the previously prepared 
photocleavage samples were loaded onto the wells.  More ethidium bromide was added to the 
running buffer and electrophoresis was conducted at 161 V for 3 h.  Gel images were visualized 
on a VWR Scientific Transilluminator and captured using a Canon Powershot A4640. 
 
2.6 UV-visible Studies with CT-DNA 
2.6.1 Dye Titration without Salt 
 
UV-visible experiments were conducted by preparing samples containing compound 1 or 
2 was and a combination of the following stock solutions: 
475 µL   ddH2O 
50 µL   10 mM Sodium phospate buffer (pH 7) 
25 µL    50 µM Dye  
 
The solution was allowed to equilibrate in the dark for 60 min.  Absorbance spectrum of 
the compound was recorded after 1 h.  CT-DNA (0 – 485 µM) was added to the sample in 20 µL 
increments and allowed to equilibrate for in the dark for 60 min after each turn.  A spectrum was 
recorded after each equilibration in a 1 cm quartz cuvettes (Starna).  Absorbance data were 
plotted as a function of wavelength.  Absorbance was corrected for volume changes using the 
equation below for all UV-visible experiments: 
Acorr = Aexp × (1000 + V)/1000 
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2.6.2 Dye Titration with Addition of Salt 
 
Sample containing compound 1 or 2 was prepared by combining the following stock 
solutions: 
220 µL    ddH2O 
50 µL      10 mM Sodium phospate buffer 
25 µL      50 µM Dye  
75 µL      150 mM NaCl 
130 µL    260 mM KCl 
 
The solution was allowed to equilibrate in the dark for 60 min.  Absorbance spectrum of the 
compound was recorded after an hour.  CT-DNA (0 – 485 µM) was added to the sample in 20 
µL increments and allowed to equilibrate for in the dark for 60 min after each addition.  A 
spectrum was recorded after each equilibration in 1cm quartz cuvettes (Starna).  Absorbance data 
was plotted as a function of wavelength. 
2.7 DNA Melting Studies 
 
Individual 1 mL solutions containing 30 uM bp of CT-DNA in 10 mM sodium phosphate 
buffer at pH 7.0 were prepared with varying concentrations (0-10 µM) of compound 1 or 2.  
Samples were equilibrated in the dark for 60 min and transferred into 1.5 mL cuvettes (Starna).  
DNA absorbance was measured as a function of increasing temperature from 25 to 95 oC at a 
rate of 0.5 oC min-1.  Data was analyzed using KaleidaGraph version 3.6.4 software.  Graphs 
were normalized using Equation 1 and the first derivative ∆A260/∆T of the plot was using to 
determine the Tm of CT-DNA in the presence of each dye.   
ANormalized = 
A
CT-DNA
Alowest
AhighestAlowest
                     (1) 
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3 Results and Discussion 
3.1 Synthesis of N,N-Dimethyl-N’-(9-methylanthracenyl)ethylenediamine 
Compound 2 was synthesized according to procedures described by Bag and Bharadwaj 
[37].  Final product was obtained from the reaction of 9-anthraldehyde with N,N-
dimethylethylenediamine.  A brown semi-solid product 2 was obtained as expected in the 
literature.  The product was characterized using 1H NMR and ESI MS.  The literature reported a 
yield of 92% and our experimental yield was 83%.  
(B) 
(B) 
Figure 3.1:  (A) ESI-MS, (B) HRMS of compound 2. 
100%MeOH+0.1%HCOOH 17:51:01  03-Mar-2011
m/z
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%
0
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BLESSING_NMEA_GRANT_030311 66 (1.228) Cm (65:66) TOF MS ES+ 
9.70e3191.2
279.4
307.5
17:58:38  03-Mar-2011
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%
0
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BLESSING_NMEA_HRMS_GRANT_030311 44 (0.814) AM (Cen,4, 80.00, Ar,5000.0,556.28,0.70); Sm (SG, 2x3.00); Cm (30:44)
1.81e4279.1856
307.1808
*
556.2771469.2603
  
 
The mass spectrum of the product
provided strong evidence of that the product was indeed synthesi
278.4 g/mol and the addition of a proton will give the observed parent peak
mass spectrometry analysis reported an exact mass of 279.1856 and the calculated mass of the 
compound is 279.1861.  A strong fragment peak is also observed at 191.2 indicating the 
dissociation of the product to give the anthracene (An
stable ion since the secondary nitrogen would form a stable cation if
form the compound. 
Figure 3.2:  1H NMR of compound 
(s, 2H, CH2), 2.72 (t, 2H, CH2), 4.73 (s, 2H
7.88 (d, 2H, An-H), 8.42 (m, 3H, An
 showed a molecular ion peak M+H at 279
zed since its average mass
.  Furthermore, the 
-CH2-) fragment.  This would be the most 
 protonated and
2 (400 MHz, CDCl3, 25oC):  δ = 2.17 (s, 6H, 2×CH
, An-CH2), 7.44 (t, 2H, An-H), 7.52 (t, 2H
-H). 
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.4 m/z.  This 
 is 
 dissociate 
 
3), 2.49 
, An H), 
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The 1H NMR spectrum showed supporting evidence of compound 2 synthesis.  Chemical 
shifts were similar to what was reported in the literature [37].  The proton attached to the 
secondary amine and the methyl group directly attached to the anthracene ring were not observed 
on the spectrum.  This could be due to induction and the charge density from the anthracene ring.  
It could also be due to experimental factors such as the solvent or temperature. 
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3.2 Photocleavage Experiments 
DNA photocleavage of pUC19 plasmid was evaluated as a function of decreasing 
concentration (10 - 0 µM) of bis-anthracene 1, and its mono-anthracene analog 2 in the presence 
and absence of salt. These reactions were conducted mimicking physiological conditions by 
adding 150 mM NaCl and/or 260 mM KCl to the reaction.  The aim of these experiments was to 
observe the effects of salt addition of photocleavage yields with both compounds.  The samples 
were aerobically irradiated for 60 min in Rayonet Photochemical Reactor.  Figures 3.3 - 3.10 
show that upon irradiation by 350 nm light, supercoiled pUC19 plasmid DNA is converted to its 
nicked and linear forms with increasing concentration of compounds 1 or 2.  The addition of 260 
mM KCl and 150 mM NaCl either enhanced or inhibited DNA photocleavage, as explained on 
the following pages. 
 
 
 
 
 
  
 
Figure 3.3: Image of 1.5% non-denaturing agarose gel depicting photocleavage o
pUC19 with decreasing concentration of 
phosphate buffer (pH 7.0) with lanes 1
 
In Figure 3.3, the addition of NaCl had no effect in enhancing photocleavage of the 
At concentrations of 10 – 2.5 µM compound 
but a slight inhibition cleavage at
NaCl.   
1 (10 - 0 µM).  Reactions contained 10 mM 
 - 7 containing 150 mM NaCl (350 nm, 60 min).
1 showed no enhancement of DNA photocleavage
 low concentrations (1 – 0.5 µM) with the addition of 
25 
 
f 23 µM bp of 
sodium 
 
DNA.  
 
150 mM 
  
 
Figure 3.4: Image of 1.5 % non-denaturing agarose gel depicting photocleavag
pUC19 with decreasing concentration of 
phosphate buffer (pH 7.0) with lanes 1
 
Next a photocleavage experiment was conducted to evaluate the effect of increasing the 
concentration of sodium chloride on photocleav
was no difference in photocleavage enhancement with the addition of a
NaCl.  Plasmid cleavage was still
e of 
1 (10 - 0 µM).  Reactions contained 10 mM 
-7 containing 260 mM NaCl (350 nm, 60 min).  
age yields.  As observed in the Figure 3.4
 higher concentration of 
 inhibited at concentrations of compound 1 (≤ 1
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23 µM bp of 
sodium 
 
, there 
 µM). 
  
 
Figure 3.5: Image of 1.5% non-denaturing agarose gel depicting photocleav
pUC19 with decreasing concentration of 
phosphate buffer (pH 7.0) with lanes 1
 
DNA photocleavage was then evaluated in the presence of 260 mM KCl.  
shows an increase in photocleavage 
supercoiled bands observed in lanes 9 and 10 are not present in lanes 2 and 3.  Photocl
inhibition was also observed at concentrations of compound 
nicked DNA in lanes 11 and 12 than lanes 5 and 6.  
NaCl (Figure 3.3), lanes 2 and 3 show an
age of 
1 (10 - 0 µM).  Reactions contained 10 mM 
 - 7 containing 260 mM KCl (350 nm, 60 min)
at 5 and 2.5 µM with the addition of 260 mM
≤ 1 µM.  There is slightly more 
When compared to the addition of
 increase of nicked DNA.   
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23 µM bp of 
sodium 
 
Figure 3.5 
 KCl.  The 
eavage 
 150 mM 
  
 
Figure 3.6: Image of 1.5% non-denaturing agarose gel depicting photocleav
pUC19 with decreasing concentration of 
phosphate buffer (pH 7.0) with lanes 1
60 min). 
 
 
The next step was to conduct a titration experiment in the presence of both 150 mM NaCl 
and 260 mM KCl.  Figure 3.6 also 
salts when compared to the addition of 150 mM 
in cleavage at higher concentrations of compound (5
DNA at 5 µM (lane 2) with the addition of both salts.  The supercoiled DNA present in lane 10 is 
no longer present in lane 3 with the addition of salt.  There is inhibition of photocleavage at 
concentration of compound ≤ 1 µ
for the addition of 260 mM KCl.
 
age of 
1 (10 - 0 µM).  Reactions contained 10 mM 
 - 7 containing 260 mM KCl and 150 mM NaCl (350 nm, 
shows an enhancement in cleavage with the addition of both 
NaCl. The picture shows the most enhancement 
 – 2.5 µM).  There is an increase of linear 
M.  This effect is similar to the amount of cleavage observed 
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23 µM bp of 
sodium 
  
 
Figure 3.7:  Image of 1.5 % non-
pUC19 with 2.5 µM of 1.  Reactions contained 10 mM 
lanes 1 - 7 containing 150 mM NaCl and 260 mM KCl irradiated at 350 nm for 0
 
In order to evaluate the kinetics
function of time, a time course experiment was conducted
VIII 23 was used because the transition 
the salt titration experiments.  With
DNA is almost completely cleaved when irradiated 
shows photocleavage enhancement with the addition of salt at all time points of irradiation
 
 
denaturing agarose gel depicting photocleavage of 
sodium phosphate buffer (pH 7.0) with 
 of photocleavage of pUC19 with compound 
.  In this experiment, 2.5 
from supercoiled to nicked DNA was more distinct in 
 addition of 150 mM NaCl and 260 mM KCl, pUC19 plasmid 
for 20 min at 350 nm.  The picture also 
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23 µM bp of 
-60 min. 
1 as a 
µM of AL-
. 
  
 
Figure 3.8: Image of 1.5% non-denaturing agarose gel depicting photocleavage of 
pUC19 with decreasing concentration of 
phosphate buffer (pH 7.0) with lanes 1
 
With the synthesis of the 
experiments were conducted to monitor cleavage yields in the presence of salt.  
addition of 150 mM NaCl showed marked inhibition 
concentrations of 2.  This image 
µM concentrations of compound
2 (10 - 0 µM).  Reactions contained 10 mM 
 - 7 containing 150 mM NaCl (350 nm, 60 min).
2, the mono-anthracene analog of compound 1, photocleavage 
In
of photocleavage at 1.0 and 0.5 
also shows evidence of a decrease in linear DNA from 10 
 with the addition of NaCl. 
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23 µM bp of 
sodium 
 
 Figure 3.8, the 
µM 
– 2.5 
  
 
Figure 3.9: Image of 1.5 % non-denaturing agarose gel depicting 
pUC19 with decreasing concentration of 
phosphate buffer (pH 7) with lanes 1
 
Next, a titration experiment of compound 
conducted. Figure 3.9 indicates that 
This result is very similar to the 150 mM
cleavage at low dye concentration (1
 
 
photocleavage of 
2 (10 - 0 µM).  Reactions contained 10 mM 
 - 7 containing 260 mM KCl (350 nm, 60 min).
2 with the addition of 260 mM KCl was 
the addition of 260 mM KCl reduced photocleavage
 NaCl addition experiment, showing inhibition of DNA 
 - 0.5 µM).  
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sodium 
 
 yields.  
  
 
Figure 3.10: Image of 1.5% non-
pUC19 with decreasing concentration of 
phosphate buffer (pH 7) with lanes 1
min). 
 
Lastly, a photocleavage experiment with the addition of both 150 mM NaCl and 260 mM 
KCl was conducted.  In contrast to the addition of 260 mM KCl
appear to change photocleavage at concentrations of 
significant inhibition were still observed
 
denaturing agarose gel depicting photocleavage of 
2 (10 - 0 µM).  Reactions contained 10 mM 
 - 7 containing 260 mM KCl and 150 mM NaCl (350 nm, 60 
, the addition of both salts did not 
2 ranging from 10 – 2.5 µM.  However, 
 at low concentrations of compound 2 (1 
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23 uM bp of 
sodium 
– 0.5 µM). 
  
 
Figure 3.11:  Agarose gel image of image of anthr
dye concentrations (10 - 0 µM) and addition of 150 mM NaCl, 260 mM KCl (lanes 1
Reactions contained 10 mM phosphate buffer (pH 7) and were irradiated at 350 nm for 60 min.
 
 The gel images displayed in Figure 3.11
group with experimental conditions similar to photocleavage of compound 
compounds in Figure 3.12 were used to analyze the effects of salt concentration on DNA 
photocleavage. Compounds 4 and 6 (Figure 3.11
compound 1 and 2 with the addition of 150 mM NaCl and 260 mM KC
compounds 4 and 6 showed indicated
to external binding with the addition of both salts.  Methylene blue
 
acene based chromophores with de
 are experiments conducted in the Grant research 
1 and 
) show more photocleavage enhancement
l.  UV-visible studies of 
 intercalation to the DNA helix and change in conformation 
 5 is a known 
33 
creasing 
 - 7).  
  
2.  The 
 than 
DNA 
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intercalator and was used as a control during these experiments.  As seen in the picture above, 
the photocleavage yields for methylene blue show inhibition of photocleavage with the addition 
of salt.  This result suggests that external agents are more effective at cleaving DNA than 
intercalating agents, with the addition of salt.  These results also suggest that compound 2 could 
possibly be an intercalator since inhibition of photocleavage is observed with the addition of salt.   
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 3.12:  Structure of photocleavage dyes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ML-Vic (4) 
H
9-MATM (6) 
Methylene Blue (5) 
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3.3 UV-visible Titrations 
UV-visible titrations were used to monitor the DNA binding of compounds 1 and 2.  The 
reactions were recorded in the presence of increasing concentrations of CT-DNA (0 – 485 µM 
bp).  The titration samples were allowed to equilibrate in the dark for 60 min after each DNA 
addition.  The solutions in Figures 3.13 and 3.15 also contained 150 mM NaCl and 260 mM KCl, 
mimicking physiological conditions in the cell nucleus [27].  Absorbance was corrected for 
volume changes. 
 
Figure 3.13: UV-visible spectra of 50 µM of 1 with increasing concentrations of CT-DNA.  
The solution contained 10 mM phosphate buffer (pH 7.0).  Spectra were adjusted for dilution of 
sample. 
 
 UV-visible studies of compound 1 with increasing concentrations of CT-DNA (0 – 387 
µM) were performed to monitor absorbance and maximum wavelenghts as the compound binds 
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to DNA.  Figure 3.13 compares the absorbance curve of 1 with and without the addition of CT-
DNA.  This figure shows a hypochromic and bathochromic shift with increasing concentrations 
of DNA.  This shift in absorbance and wavelength is evidence of DNA intercalation [20, 38-40].  
The plot above also indicates that compound 1 readily intercalates between base pairs, reaching 
saturation by 145 µM bp CT-DNA.   
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Figure 3.14: UV-Visible spectra 50 µM of 1 with increasing concentration of CT-DNA and 
addition of 260 mM KCl, 150 mM NaCl in 10 mM phosphate buffer (pH 7.0).  Spectra were 
adjusted for dilution of sample. 
 
Figure 3.14 compares the absorbance curve of 1 in 150 mM NaCl and 260 mM KCl with 
the compound in the presence of increasing concentrations of CT- DNA. This figure shows 
hypochromicity and bathochromicity increasing concentration of DNA.  As DNA concentration 
is increased, the spectral changes observed in Figure 3.13 (no added salt) become more apparent. 
The spectral changes occurs gradually as more DNA is added to the sample.  The spectrum also 
shows that binding of compound 1 reaches saturation at 387 µM bp of DNA. 
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 (A) 
       (B) 
 
Figure 3.15: (A) UV-visible spectra of 50 µM of 2 with increasing concentrations of CT DNA in 
10 mM phosphate buffer (pH 7.0). (B) Plot of absorption of 2 at 367 nm as a function of CT 
DNA concentration.  Spectra were adjusted for dilution of sample. 
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 Similarly, the absorbance spectra of compound 2 was also monitored, seeing as it showed 
no enhance of photocleavage with addition of salt.  Figure 3.15 compares the absorbance curve 
of 2 with and without the addition of CT DNA.  This figure shows a hypochromic shift with 
increasing concentrations of DNA.  There seems to be a shift from groove binding to 
intercalation mode as a shoulder starts to appear at 393 nm with an increase in DNA 
concentration.   This spectrum also suggests that there are two binding modes present with a 
rapid decrease in absorbance initially and then more slowly as DNA concentration increases 
(Figure 3.15B).  An isosbestic point is also observed at 392 nm (Figure 3.15A); this indicates the 
conversion of one type of chromophore to another.  By the addition of 485 µM of DNA, a 
saturation point has still not been observed.  Hence, compound 2 appears to bind to DNA with 
weaker affinity than compound 1.  Previous research conducted by Kumar and co-workers has 
shown that anthracene ligands that show a bathochromic and hypochromic shift in UV-visible 
spectra are DNA intercalators, while compound which show hypochromicity and no 
bathochromicity are DNA groove binders [20, 26]. 
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 (A) 
        (B) 
Figure 3.16:  (A) UV-Visible spectra 50 µM of 2 in the presence of CT DNA, 260 mM KCl, and 
150 mM NaCl in 10 mM phosphate buffer (pH 7.0).  (B)  Absorption of 2 at 367 nm as a 
function of CT-DNA concentration.  Spectra were adjusted for dilution of sample. 
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Figure 3.16 compares the absorbance curve of 2 in 150 mM NaCl and 260 mM KCl with 
increasing concentrations of CT DNA. This figure shows hypochromicity but no 
bathochromicity with increasing concentration of DNA.  When compared to the absorbance 
spectra without salt (Figure 3.15), the second λmax is not present.  The data are consistent with a 
model in which the compound is groove bound to the helix.  Unlike the no salt experiment, 
compound 2 reached saturation at 387 µM bp of DNA with the addition of both salts.  The 
shallow decrease in absorbance observed in the graph (Figure 3.16B) is characteristic of a groove 
binding agent [32].  
 
 
Table 3.1:  UV-visible maximum absorbance and wavelengths 
Dye Abs (no salt) λmax (no salt) Abs (salt) λmax (salt) 
50 µM Comp 1 0.4699 367.5 nm 0.4802 368.0 nm 
Comp 1 @ sat. 0.3407 375.0 nm 0.2130 374.0 nm 
50 µM Comp 2 0.3407 366.5 nm 0.3305 367.0 nm 
Comp 2 @ sat 0.1578 368.0 nm 0.2417 367.0 nm 
 
 Table 3.1 compares the maximum absorbance and wavelengths of compound 1 and 2 
with and without the presence of salt based on data from the UV-visible spectrum.  At 50 µM 
concentration of both compounds, the addition of salt had barely any effect in increasing or 
decreasing the absorbance of the compound.  On the other hand, the addition of salt had a 
significant effect on the wavelength at maximum absorbance shifting by 7.5 nm for compound 1 
and 1.5 nm for compound 2. 
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Figure 3.17: Displays UV-visible spectrum of an anthracene based chromophore 4 with 
increasing concentrations of CT DNA (a) and addition of 150 mM NaCl and 260 mM KCl (b) 
[31]. 
 
 The image above was from an experiment conducted the Grant research group comparing 
the absorbance of an anthracene chromophore N1-(anthracen-9-ylmethyl)-N2-((6-
((dimethylamino)methyl)pyridine-2-yl)methyl-N1,N2-dimentylethane-1,2-diamine (4).  Under 
conditions of high salt concentration ~ 150 mM NaCl and 260 mM KCl, the compound shifts 
from intercalation to external mode.  This change is conformation is characterized by a constant 
λmax and very minimal change in absorbance as the DNA concentration increases.  
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3.4 DNA Melting Studies 
 
DNA thermal denaturation studies were used to assess the binding affinity and stabilization 
of the duplex by compound 1 or 2.  Most DNA intercalators are known to stabilize the helix by 
increasing π-π stacking and electrostatic interactions.  This increasing in stability also leads to an 
increase in DNA melting temperature (Tm) [12].  The Tm is the point at which half the DNA is 
double stranded and the other half is single stranded.  In experiments testing for Tm values, 30 
µM bp CT DNA were used to evaluate its stability with increasing concentrations of either 1 or 
2.   Reaction samples containing deionized water, 10 mM sodium phosphate buffer, CT DNA, 
and anthracene dye were allow to equilibrate in the dark for 60 min before undergoing thermal 
denaturation. 
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Figure 3.18:  Thermal melting curves of 30 µM bp CT DNA with addition of 1 (0 – 10 µM) in 10 
mM sodium phosphate buffer (pH 7.0). 
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 The figure above shows that the melting temperature of calf thymus DNA increases with 
increasing concentrations of compound 1.  At 10 µM of 1, an average ∆Tm of 21 oC is observed.  
Such a high increase in Tm is characteristic of a strong ligand/DNA interaction often observed in 
bis-intercalators [12].    
 
 
Figure 3.19:  Plot of the ∆Tm as a function of the ratio of the concentration of 1 to the 
concentration of CT DNA. 
 
 The figure above shows a linear relationship between the change in melting temperature 
and the r value (the ratio of the dye concentration to DNA concentration). The melting 
temperature at saturation was not obtained because the instrument could only go up to 95oC.  
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Figure 3.20:  Thermal melting curves of 30 µM bp CT DNA with addition of 2 (0 – 10 µM ) in 
10 mM sodium phosphate buffer (pH 7.0). 
 
The figure above shows that the melting temperature of calf thymus DNA increases with 
increasing concentrations of compound 2.  At 10 µM of 1, a ∆Tm of 2 oC is observed.  Unlike the 
bis-anthracene, very little increase in melting temperature is observed when 2 is added.  These 
data agree with the UV-visible titrations suggesting that 2 weakly associates with the DNA helix.  
Groove binding anthracenes usually have very small ∆Tm values [38].  Hence, this result 
complies with the UV-visible data 
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4 Conclusion 
 Upon completion and analysis of photocleavage experiments, one can conclude that 
compound 1 and 2 are capable of inducing cleavage of DNA when activated by 350 nm light.  It 
can also be concluded that DNA cleavage is enhanced at high concentrations of the compound 1 
(10-2.5 µM) and inhibited at low concentrations (1.0-0 µM) with addition of salt.  The addition 
of KCl enhances photocleavage whereas lower yields are observed with the addition of NaCl.  
The addition of both salts showed more cleavage than the addition of the single potassium 
chloride salt. Importantly, the high levels of cleavage caused by salt were unexpected.  It was 
also observed that an increase in salt concentration also yields an increase in DNA cleavage 
when irradiated in 350 nm light.   
Compound 2 showed inhibition of photocleavage with the addition of single salts and no 
enhancement with both salts. For most other DNA photosensitizers, photocleavage yields are 
decreased due to the condensation of DNA by the salt or the competition by salt for binding sites 
on the DNA [12].  Spectroscopic analysis of 1 increasing concentration of CT DNA indicated 
intercalation of this compound with and without the addition of salt.  The DNA melting 
experiments with the addition of the bis-anthracene dye yielded a much higher ∆Tm than the 
mono-anthracene.  Such high Tm values are usually characteristic of a strong binding affinity 
which is observed in intercalation [38].   
 Based on photocleavage and UV-visible results by the Grant research group, it can 
concluded that external binding mode induced by the addition of salt leads to an increase in DNA 
photocleavage as observed in the case of compound 4.  If the addition of salt produces groove 
binding, there will be an inhibition of photocleavage as seen in experiments with compound 2.  
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